Ischemia but no obstructive coronary artery disease: more than meets the eye

References

• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492. doi: 10.1161/CIR.0000000000000558.
   PubMed Web of Science ®Google Scholar
• Bairey Merz CN, Pepine CJ, Walsh MN, et al. Ischemia and No Obstructive Coronary Artery Disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation. 2017;135(11):1075–1092. doi: 10.1161/CIRCULATIONAHA.116.024534.
   PubMed Web of Science ®Google Scholar
• Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35(17):1101–1111. doi: 10.1093/eurheartj/eht513.
   PubMed Web of Science ®Google Scholar
• Shimokawa H, Suda A, Takahashi J, et al. Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group. Eur Heart J. 2021;42(44):4592–4600. doi: 10.1093/eurheartj/ehab282.
   PubMed Web of Science ®Google Scholar
• Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the women’s ischemia syndrome evaluation study and the St James women take heart project. Arch Intern Med. 2009;169(9):843–850. doi: 10.1001/archinternmed.2009.50.
   PubMedGoogle Scholar
• Jespersen L, Hvelplund A, Abildstrøm SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734–744. doi: 10.1093/eurheartj/ehr331.
   PubMed Web of Science ®Google Scholar
• Saraste A, Knuuti J. ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: recommendations for cardiovascular imaging. Herz. 2020;45(5):409–420. doi: 10.1007/s00059-020-04935-x.
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Shaw RE, Merz CN, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation. 2008;117(14):1787–1801. doi: 10.1161/CIRCULATIONAHA.107.726562.
   PubMed Web of Science ®Google Scholar
• Merz NB, Johnson BD, Kelsey PSF, et al. Diagnostic, prognostic, and cost assessment of coronary artery disease in women. Am J Manag Care. 2001;7(10):959–965.
   PubMed Web of Science ®Google Scholar
• Maddox TM, Stanislawski MA, Grunwald GK, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312(17):1754–1763. doi: 10.1001/jama.2014.14681.
   PubMed Web of Science ®Google Scholar
• Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886–895. doi: 10.1056/NEJMoa0907272.
   PubMed Web of Science ®Google Scholar
• Khuddus MA, Pepine CJ, Handberg EM, et al. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). J Interv Cardiol. 2010;23(6):511–519. doi: 10.1111/j.1540-8183.2010.00598.x.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Samuels BA, Li W, et al. Safety of provocative testing with intracoronary acetylcholine and implications for standard protocols. J Am Coll Cardiol. 2022;79(24):2367–2378. doi: 10.1016/j.jacc.2022.03.385.
   PubMed Web of Science ®Google Scholar
• AlBadri A, Bairey Merz CN, Johnson BD, et al. Impact of abnormal coronary reactivity on long-term clinical outcomes in women. J Am Coll Cardiol. 2019;73(6):684–693. doi: 10.1016/j.jacc.2018.11.040.
   PubMed Web of Science ®Google Scholar
• Sara JD, Widmer RJ, Matsuzawa Y, et al. Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv. 2015;8(11):1445–1453. doi: 10.1016/j.jcin.2015.06.017.
   PubMed Web of Science ®Google Scholar
• Gupta A, Taqueti VR, van de Hoef TP, et al. Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease. Circulation. 2017;136(24):2325–2336. doi: 10.1161/CIRCULATIONAHA.117.029992.
   PubMed Web of Science ®Google Scholar
• Ziadi MC, Dekemp RA, Williams KA, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58(7):740–748. doi: 10.1016/j.jacc.2011.01.065.
   PubMed Web of Science ®Google Scholar
• Pasupathy S, Tavella R, Beltrame JF. Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): the past, present, and future management. Circulation. 2017;135(16):1490–1493. doi: 10.1161/CIRCULATIONAHA.117.027666.
   PubMed Web of Science ®Google Scholar
• Agewall S, Beltrame JF, Reynolds HR, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017;38(3):143–153.
   PubMed Web of Science ®Google Scholar
• Reynolds HR, Maehara A, Kwong RY, et al. Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women. Circulation. 2021;144(12):e209–e210. doi: 10.1161/CIRCULATIONAHA.121.055516.
   PubMedGoogle Scholar
• Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(18):e891–e908. doi: 10.1161/CIR.0000000000000670.
   PubMed Web of Science ®Google Scholar
• Mieres JH, Heller GV, Hendel RC, et al. Signs and symptoms of suspected myocardial ischemia in women: results from the What is the Optimal Method for Ischemia Evaluation in WomeN? Trial. J Womens Health (Larchmt). 2011;20(9):1261–1268. doi: 10.1089/jwh.2010.2595.
   PubMed Web of Science ®Google Scholar
• Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021;144(22):e368–e454. doi: 10.1161/CIR.0000000000001030.
   Web of Science ®Google Scholar
• Schumann CL, Mathew RC, Dean JL, et al. Functional and economic impact of INOCA and influence of coronary microvascular dysfunction. JACC Cardiovasc Imaging. 2021;14(7):1369–1379. doi: 10.1016/j.jcmg.2021.01.041.
   PubMed Web of Science ®Google Scholar
• Gulati M, Khan N, George M, et al. Ischemia with no obstructive coronary artery disease (INOCA): a patient self-report quality of life survey from INOCA international. Int J Cardiol. 2023;371:28–39. doi: 10.1016/j.ijcard.2022.09.047.
   PubMed Web of Science ®Google Scholar
• Aldiwani H, Zaya M, Suppogu N, et al. Angina hospitalization rates in women with signs and symptoms of ischemia but no obstructive coronary artery disease: a report from the WISE (Women’s Ischemia Syndrome Evaluation). J Am Heart Assoc. 2020;9(4):e013168.
   PubMed Web of Science ®Google Scholar
• Humphries KH, Pu A, Gao M, et al. Angina with “normal” coronary arteries: sex differences in outcomes. Am Heart J. 2008;155(2):375–381. doi: 10.1016/j.ahj.2007.10.019.
   PubMed Web of Science ®Google Scholar
• Kamlesh K. Microvascular coronary dysfunction in women: pathlophysiology, diagnosis, and management. Curr Probl Cardiol. 2011;36(8):27.
   Web of Science ®Google Scholar
• Shaw LJ, Merz CN, Pepine CJ, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health–National Heart, Lung, and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation. Circulation. 2006;114(9):894–904. doi: 10.1161/CIRCULATIONAHA.105.609990.
   PubMed Web of Science ®Google Scholar
• Ferreira Vanessa M, Berry C. The health economics of ischemia with nonobstructive coronary arteries. ∗JACC Cardiovasc Imaging. 2021;14(7):1380–1383. doi: 10.1016/j.jcmg.2021.03.017.
   PubMed Web of Science ®Google Scholar
• Feenstra RGT, Boerhout CKM, Woudstra J, et al. Presence of coronary endothelial dysfunction, coronary vasospasm, and adenosine-mediated vasodilatory disorders in patients with ischemia and nonobstructive coronary arteries. Circ Cardiovasc Interv. 2022;15(8):e012017. doi: 10.1161/CIRCINTERVENTIONS.122.012017.
   PubMed Web of Science ®Google Scholar
• Godo S, Takahashi J, Yasuda S, et al. Endothelium in coronary macrovascular and microvascular diseases. J Cardiovasc Pharmacol. 2021;78(Suppl 6):S19–s29. doi: 10.1097/FJC.0000000000001089.
   PubMedGoogle Scholar
• Godo S, Suda A, Takahashi J, et al. Coronary microvascular dysfunction. Arterioscler Thromb Vasc Biol. 2021;41(5):1625–1637. doi: 10.1161/ATVBAHA.121.316025.
   PubMed Web of Science ®Google Scholar
• Berry C, Sidik N, Pereira AC, et al. Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions. J Am Heart Assoc. 2019;8(3):e011104.
   PubMed Web of Science ®Google Scholar
• Nelson MD, Wei J, Bairey Merz CN. Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg? Eur Heart J. 2018;39(10):850–852. doi: 10.1093/eurheartj/ehx818.
   PubMed Web of Science ®Google Scholar
• Masumoto A, Mohri M, Shimokawa H, et al. Suppression of coronary artery spasm by the rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation. 2002;105(13):1545–1547. Apr 2doi: 10.1161/hc1002.105938.
   PubMed Web of Science ®Google Scholar
• Shimokawa H. 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside. Eur Heart J. 2014;35(45):3180–3193. doi: 10.1093/eurheartj/ehu427.
   PubMed Web of Science ®Google Scholar
• Ong P, Athanasiadis A, Borgulya G, et al. 3-Year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up. J Am Coll Cardiol. 2011;57(2):147–152. doi: 10.1016/j.jacc.2010.08.626.
   PubMed Web of Science ®Google Scholar
• Mehta PK, Gaignard S, Schwartz A, et al. Traditional and emerging sex-specific risk factors for cardiovascular disease in women. Rev. Cardiovasc. Med. 2022;23(8):288. doi: 10.31083/j.rcm2308288.
   Google Scholar
• Waheed N, Elias-Smale S, Malas W, et al. Sex differences in non-obstructive coronary artery disease. Cardiovasc Res. 2020;116(4):829–840. doi: 10.1093/cvr/cvaa001.
   PubMed Web of Science ®Google Scholar
• Haas AV, Rosner BA, Kwong RY, et al. Sex differences in coronary microvascular function in individuals with type 2 diabetes. Diabetes. 2019;68(3):631–636. Mardoi: 10.2337/db18-0650.
   PubMed Web of Science ®Google Scholar
• Ohkuma T, Komorita Y, Peters SAE, et al. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals. Diabetologia. 2019;62(9):1550–1560. Sepdoi: 10.1007/s00125-019-4926-x.
   PubMed Web of Science ®Google Scholar
• Bajaj NS, Osborne MT, Gupta A, et al. Coronary microvascular dysfunction and cardiovascular risk in obese patients. J Am Coll Cardiol. 2018;72(7):707–717. doi: 10.1016/j.jacc.2018.05.049.
   PubMed Web of Science ®Google Scholar
• Mehta PK, Levit RD, Wood MJ, et al. Chronic rheumatologic disorders and cardiovascular disease risk in women. Am Heart J Plus Cardiol Res Pract. 2023;27:100267. doi: 10.1016/j.ahjo.2023.100267.
   Google Scholar
• Chakrala T, Prakash R, Valdes C, et al. Circulating biomarkers in coronary microvascular dysfunction. J Am Heart Assoc. 2023;12(12):e029341.
   PubMed Web of Science ®Google Scholar
• Recio-Mayoral A, Mason JC, Kaski JC, et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J. 2009;30(15):1837–1843. doi: 10.1093/eurheartj/ehp205.
   PubMed Web of Science ®Google Scholar
• Abramson JL, Hooper WC, Jones DP, et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis. 2005;178(1):115–121. doi: 10.1016/j.atherosclerosis.2004.08.007.
   PubMed Web of Science ®Google Scholar
• AlBadri A, Lai K, Wei J, et al. Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: a report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE). PLoS One. 2017;12(5):e0177684. doi: 10.1371/journal.pone.0177684.
   PubMed Web of Science ®Google Scholar
• Eapen DJ, Manocha P, Ghasemzadeh N, et al. Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events. J Am Heart Assoc. 2014;3(5):e001118.
   PubMed Web of Science ®Google Scholar
• Mekonnen G, Corban MT, Hung OY, et al. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease. Atherosclerosis. 2015;239(1):55–60. Mardoi: 10.1016/j.atherosclerosis.2014.12.025.
   PubMed Web of Science ®Google Scholar
• Prescott E, Bove KB, Bechsgaard DF, et al. Biomarkers and coronary microvascular dysfunction in women with angina and no obstructive coronary artery disease. JACC: advances. 2023;2(2):100264. doi: 10.1016/j.jacadv.2023.100264.
   Google Scholar
• Moreau KL, Hildreth KL, Meditz AL, et al. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab. 2012;97(12):4692–4700. Decdoi: 10.1210/jc.2012-2244.
   PubMed Web of Science ®Google Scholar
• Sickinghe AA, Korporaal SJA, den Ruijter HM, et al. Estrogen contributions to microvascular dysfunction evolving to heart failure with preserved ejection fraction. Front Endocrinol (Lausanne). 2019;10:442. doi: 10.3389/fendo.2019.00442.
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Wildman RP, Matthews K, et al. Progression rates of carotid intima-media thickness and adventitial diameter during the menopausal transition. Menopause. 2013;20(1):8–14. doi: 10.1097/gme.0b013e3182611787.
   PubMed Web of Science ®Google Scholar
• Stevenson JC, Collins P, Hamoda H, et al. Cardiometabolic health in premature ovarian insufficiency. Climacteric. 2021;24(5):474–480. doi: 10.1080/13697137.2021.1910232.
   PubMed Web of Science ®Google Scholar
• Lakhani K, Leonard A, Seifalian AM, et al. Microvascular dysfunction in women with polycystic ovary syndrome. Hum Reprod. 2005;20(11):3219–3224. Novdoi: 10.1093/humrep/dei199.
   PubMed Web of Science ®Google Scholar
• Cho L, Davis M, Elgendy I, et al. Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-Art review. J Am Coll Cardiol. 2020;75(20):2602–2618. doi: 10.1016/j.jacc.2020.03.060.
   PubMed Web of Science ®Google Scholar
• Minissian MB, Mehta PK, Hayes SN, et al. Ischemic heart disease in young women: JACC review topic of the week. J Am Coll Cardiol. 2022;80(10):1014–1022. doi: 10.1016/j.jacc.2022.01.057.
   PubMed Web of Science ®Google Scholar
• Chrissobolis S, Budzyn K, Marley PD, et al. Evidence that estrogen suppresses Rho-Kinase function in the cerebral circulation in vivo. Stroke. 2004;35(9):2200–2205. doi: 10.1161/01.STR.0000136951.85586.c8.
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506–e532. doi: 10.1161/CIR.0000000000000912.
   PubMed Web of Science ®Google Scholar
• Kawano H, Motoyama T, Ohgushi M, et al. Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med. 2001;135(11):977–981. doi: 10.7326/0003-4819-135-11-200112040-00009.
   PubMed Web of Science ®Google Scholar
• Mehta PK, Sharma A, Bremner JD, et al. Mental stress-induced myocardial ischemia. Curr Cardiol Rep. 2022;24(12):2109–2120. doi: 10.1007/s11886-022-01821-2.
   PubMed Web of Science ®Google Scholar
• Vaccarino V, Shah AJ, Rooks C, et al. Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med. 2014;76(3):171–180. doi: 10.1097/PSY.0000000000000045.
   PubMed Web of Science ®Google Scholar
• Lima BB, Hammadah M, Kim JH, et al. Association of transient endothelial dysfunction induced by mental stress with major adverse cardiovascular events in men and women with coronary artery disease. JAMA Cardiol. 2019;4(10):988–996. doi: 10.1001/jamacardio.2019.3252.
   PubMed Web of Science ®Google Scholar
• Hayek SS, Ko YA, Awad M, et al. Depression and chest pain in patients with coronary artery disease. Int J Cardiol. 2017;230:420–426. doi: 10.1016/j.ijcard.2016.12.091.
   PubMed Web of Science ®Google Scholar
• Beitman BD, Mukerji V, Lamberti JW, et al. Panic disorder in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol. 1989;63(18):1399–1403. doi: 10.1016/0002-9149(89)91056-4.
   PubMed Web of Science ®Google Scholar
• Vermeltfoort IA, Raijmakers PG, Odekerken DA, et al. Association between anxiety disorder and the extent of ischemia observed in cardiac syndrome X. J Nucl Cardiol. 2009;16(3):405–410. doi: 10.1007/s12350-008-9032-2.
   PubMed Web of Science ®Google Scholar
• Gould KL, Johnson NP, Bateman TM, et al. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol. 2013;62(18):1639–1653. doi: 10.1016/j.jacc.2013.07.076.
   PubMed Web of Science ®Google Scholar
• Thomson LE, Wei J, Agarwal M, et al. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women’s Ischemia Syndrome Evaluation. Circ Cardiovasc Imaging. 2015;8(4):e002481. doi: 10.1161/CIRCIMAGING.114.002481.
   PubMed Web of Science ®Google Scholar
• Shufelt CL, Thomson LE, Goykhman P, et al. Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. Cardiovasc Diagn Ther. 2013;3(3):153–160.
   PubMedGoogle Scholar
• Murthy VL, Naya M, Foster CR, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126(15):1858–1868. Oct 9doi: 10.1161/CIRCULATIONAHA.112.120402.
   PubMed Web of Science ®Google Scholar
• Taqueti VR, Hachamovitch R, Murthy VL, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131(1):19–27. doi: 10.1161/CIRCULATIONAHA.114.011939.
   PubMed Web of Science ®Google Scholar
• Ford Thomas J, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina. J Am Coll Cardiol. 2018;72(23 Pt A):2841–2855. doi: 10.1016/j.jacc.2018.09.006.
   PubMed Web of Science ®Google Scholar
• Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830–840. doi: 10.1056/NEJMra061889.
   PubMed Web of Science ®Google Scholar
• Demir OM, Boerhout CKM, de Waard GA, et al. Comparison of doppler flow velocity and thermodilution derived indexes of coronary physiology. JACC Cardiovasc Interv. 2022;15(10):1060–1070. doi: 10.1016/j.jcin.2022.03.015.
   PubMed Web of Science ®Google Scholar
• Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation. 2006;113(17):2054–2061. doi: 10.1161/CIRCULATIONAHA.105.603522.
   PubMed Web of Science ®Google Scholar
• Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101(9):948–954. doi: 10.1161/01.cir.101.9.948.
   PubMed Web of Science ®Google Scholar
• Ong P, Athanasiadis A, Sechtem U. Patterns of coronary vasomotor responses to intracoronary acetylcholine provocation. Heart. 2013;99(17):1288–1295. doi: 10.1136/heartjnl-2012-302042.
   PubMed Web of Science ®Google Scholar
• Johnston N, Schenck-Gustafsson K, Lagerqvist B. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Eur Heart J. 2011;32(11):1331–1336. doi: 10.1093/eurheartj/ehr009.
   PubMed Web of Science ®Google Scholar
• Luu JM, Wei J, Shufelt CL, et al. Clinical practice variations in the management of ischemia with no obstructive coronary artery disease. J Am Heart Assoc. 2022;11(19):e022573.
   PubMed Web of Science ®Google Scholar
• Chow BJW, Small G, Yam Y, et al. Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease. Arterioscler Thromb Vasc Biol. 2015;35(4):981–989. doi: 10.1161/ATVBAHA.114.304351.
   PubMed Web of Science ®Google Scholar
• Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines. Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168.
   Google Scholar
• Dibben G, Faulkner J, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2021;11(11):CD001800.
   PubMedGoogle Scholar
• Sandesara PB, Lambert CT, Gordon NF, et al. Cardiac rehabilitation and risk reduction: time to “rebrand and reinvigorate”. J Am Coll Cardiol. 2015;65(4):389–395. doi: 10.1016/j.jacc.2014.10.059.
   PubMed Web of Science ®Google Scholar
• Smith SCJr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124(22):2458–2473. doi: 10.1161/CIR.0b013e318235eb4d.
   PubMed Web of Science ®Google Scholar
• Szot W, Zając J, Kubinyi A, et al. The effects of cardiac rehabilitation on overall physical capacity and myocardial perfusion in women with microvascular angina. Kardiol Pol. 2016;74(5):431–438. doi: 10.5603/KP.a2015.0198.
   PubMed Web of Science ®Google Scholar
• Turgeon RD, Pearson GJ, Graham MM. Pharmacologic treatment of patients with myocardial ischemia with no obstructive coronary artery disease. Am J Cardiol. 2018;121(7):888–895. doi: 10.1016/j.amjcard.2017.12.025.
   PubMed Web of Science ®Google Scholar
• Takahashi J, Nihei T, Takagi Y, et al. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. Eur Heart J. 2015;36(4):228–237. doi: 10.1093/eurheartj/ehu313.
   PubMed Web of Science ®Google Scholar
• Bairey Merz CN, Pepine CJ, Shimokawa H, et al. Treatment of coronary microvascular dysfunction. Cardiovasc Res. 2020;116(4):856–870. doi: 10.1093/cvr/cvaa006.
   PubMed Web of Science ®Google Scholar
• Pizzi C, Manfrini O, Fontana F, et al. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme a reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation. 2004;109(1):53–58. doi: 10.1161/01.CIR.0000100722.34034.E4.
   PubMed Web of Science ®Google Scholar
• Handberg EM, Merz CNB, Cooper-Dehoff RM, et al. Rationale and design of the Women’s Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial. Am Heart J. 2021;237:90–103. doi: 10.1016/j.ahj.2021.03.011.
   PubMed Web of Science ®Google Scholar
• Nordenskjold AM, Agewall S, Atar D, et al. Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): rationale and design. Am Heart J. 2021;231:96–104. doi: 10.1016/j.ahj.2020.10.059.
   PubMed Web of Science ®Google Scholar
• Cannon RO, 3rd, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330(20):1411–1417. 19doi: 10.1056/NEJM199405193302003.
   PubMed Web of Science ®Google Scholar
• Shechter M, Matetzky S, Feinberg MS, et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol. 2003;42(12):2090–2095. doi: 10.1016/j.jacc.2003.05.013.
   PubMed Web of Science ®Google Scholar
• Gallone G, Baldetti L, Tzanis G, et al. Refractory angina: from pathophysiology to new therapeutic nonpharmacological technologies. JACC Cardiovasc Interv. 2020;13(1):1–19. doi: 10.1016/j.jcin.2019.08.055.
   PubMed Web of Science ®Google Scholar